Osteotoxicology: The role of lead in bone diseases

Current Opinion in Orthopaedics

Volumn 11, Issue 5, 2000, Pages 360-365

  Puzas, J Edward ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; BONE MORPHOGENETIC PROTEIN; COLLAGEN; DNA; GROWTH FACTOR; HORMONE; LEAD; OSTEONECTIN; PROTEOGLYCAN;

ALBERS SCHOENBERG DISEASE; ARTICLE; BONE DENSITY; BONE DISEASE; BONE METABOLISM; BONE REMODELING; CARTILAGE; ENCHONDRAL OSSIFICATION; GROWTH PLATE; HUMAN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; TOXICITY;

EID: 0033804244     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001433-200010000-00006     Document Type: Article

References (55)

1. Absorption, storage and excretion of lead by normal humans
2. Toxicokinetics of bone lead
3. Environmental Health Perspectives
4. Effects of lead on autocrine/paracrine regulation of growth plate chondrocytes
5. Effects of lead on growth plate chondrocyte phenotype
6. Quantitative and distributional changes in the activity of alkaline phosphatase during the maturation of cartilage
7. Proteoglycan structure in calcifying cartilage
8. A review of the primary mechanism of endochondral calcification with special emphasis on the role of cells, mitochondria and matrix vesicles
9. Role of lipids in calcification of cartilage
10. The role of mitochondria in growth plate calcification as demonstrated in a rachitic model
11. Differential expression of biological effects in maturationally distinct subpopulations of growth plate chondrocytes
12. Morphometric analysis of chondrocyte hypertrophy
13. Relationship between childhood blood lead levels and stature
14. Comparison of biometric data of children with high and low levels of lead in the blood
15. Lead exposure and growth in the early preschool child: A follow-up report from the Cincinnati Lead Study
16. The lead line in bone-a lesion apparently due to chondroclastic indigestion
17. Chemical toxic agents affecting bone growth and structure, lead
18. Xray shadows in growing bones produced by lead, their characteristics, causes, anatomical counterpart in the bone and differentiation
19. Molecular defects of bone development
20. Osteopetrosis: Current clinical considerations
21. High-resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in chicken tibia
22. Changes in osteonectin distribution and levels are associated with mineralization of the chicken tibial growth cartilage
23. Induction of bone-related proteins, osteocalcin and osteopontin and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro
24. Effect of sodium warfarin in vitamin K dependent proteins and skeletal development in the rat fetus
25. Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants
26. Resorption of implanted bone prepared from normal and warfarin treated rats
27. Regulation of osteoblastic gene expression by lead
28. Regulation of bone formation by bone morphogenetic proteins and other growth factors
29. The insulin-like growth factor system and the coupling of formation to resorption
30. Lead inhibits secretion of osteonectin/SPARC without significantly altering collagen or Hsp47 production in osteoblast-like ROS 17/2.8 cells
31. Regulation of osteoblast gene expression by lead
32. Lead inhibits the basal and stimulated responses of a rat osteblast-like cell line ROS 17/2.8 to 1,25 dihydroxyviatmin D3 and IGF-1
33. Lead inhibits 1,25 dihydroxyvitamin D3 regulation of calcium metabolism in osteoblastic osteosacoma cells, ROS 17/2.8
34. Cellular toxicity and metabolism in primary and clonal osteoblastic bone cells
35. Osteoblasts and chondrocytes are important target cells for the toxic effects of lead
36. Bone marking and lead intoxication; early pathological changes in osteoclasts
37. Lead inclusion bodies in osteoclasts
38. Stimulative effects of lead on bone resorption in organ culture
39. Effects of lead on osteoclast-like cell formation in mouse bone marrow cell cultures
40. Lead intoxication caused skeletal disease
41. Recurrent lead poisoning in a child with immobilization osteoporosis
42. Lead and osteoporosis: Mobilization of lead from bone in postmenopausal women
43. Recurrent lead poisoning in a child with immobilization osteoporosis
44. Lead poisoning from mobilization of bone stores during thyrotoxicosis
45. Blood lead levels in relation to menopause, smoking and pregnancy history
46. Contribution of tissue lead to blood lead in adult female subjects based on stable lead isotope methods
47. Lead in bone. IV. Distribution of lead in the human skeleton
48. The effect of chronic low level lead intoxication on the haversian remodelling system in dogs
49. Inhibition of intercellular matrix synthesis during ingestion of matrix lead
50. Osteoporosis and hydronephrosis in young lambs following ingestion of lead
51. Relations between lead poisoning in rabbit and man
52. Lead accumulation in the bones of aging male mice
53. A comparison of concentrations of lead in human tissue
54. Safety of some calcium supplements questioned
55. Lead content in 70 brands of dietary calcium supplements